SCHEMBL3346261

SCHEMBL3346261

COc1ccccc1-c1cc(C)nc(N2CCN(C)CC2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.57
CYP3A4 P08684 4/20 0.57
CYP2D6 P10635 3/20 0.57
CYP2C19 P33261 3/20 0.57
ALDH1A1 P00352 3/20 0.57
USP2 O75604 2/20 0.57
DRD2 P14416 2/20 0.54
HTR6 P50406 1/20 0.54
TSHR P16473 3/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
LMNA P02545 1/20 0.51
HIF1A Q16665 1/20 0.51
HSD17B10 Q99714 2/20 0.48
ALOX15 P16050 1/20 0.48
HTR3E A5X5Y0 1/20 0.48
HTR3B O95264 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3349828 0.79 HTR6 (0.68) DRD2HTR6TSHRKMT2AKDM4E
SCHEMBL19537477 0.79 HSP90AA1 (0.58) ALDH1A1TSHRKMT2AMEN1SMN1; SMN2
SCHEMBL3352972 0.77 HTR6 (0.62) CYP2C19ALDH1A1DRD2HTR6KMT2A
SCHEMBL3345464 0.77 HTR6 (0.57) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
Hydrochloric Acid SCHEMBL3347629 0.76 HTR6 (0.61) CYP2C19ALDH1A1DRD2HTR6KMT2A
SCHEMBL2165339 0.76 HRH4 (0.69) HTR3A
SCHEMBL3346394 0.74 DRD2 (0.64) ALDH1A1DRD2HTR6KMT2AMEN1
SCHEMBL3350651 0.74 DRD2 (0.57) DRD2HTR6KMT2AHTR3EHTR3B
SCHEMBL3347895 0.72 DRD2 (0.61) ALDH1A1DRD2HTR6KMT2AMEN1
SCHEMBL3347950 0.70 HTR6 (1.00) DRD2HTR6KMT2AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO claimed
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed